← All organizations

Unidad de Investigacion Medica en Enfermedades Renales

Academic/Hospital

Also known as: Unidad de Investigacion Medica en Enfermedades Renales

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jan 1, 2022

Timeline

No events for the selected filters.

Drugs by trial phase (9 distinct, 4 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

inulin

Indications

Studied for

Recent trials (5)

NCT05232370Lead sponsorPhase 2Jan 1, 2022
NCT03770611Reponsible party - principal investigatorN/AJan 7, 2019
NCT03770611Lead sponsorN/AJan 7, 2019
NCT03262363Lead sponsorPhase 2/Phase 3Aug 1, 2018
NCT02328222Lead sponsorPhase 4Jun 1, 2010

Details

Last known activity: Jan 1, 2022